Thirty Madison prioritizes and allows the cultivation of meaningful doctor-patient relationships to provide the best care for successful management of lifelong conditions
FREMONT, CA: Thirty Madison, a leading digital health company reinventing the patient experience for the estimated 133 million Americans living with chronic conditions, raised $47 million in Series B round of financing led by Polaris Partners. New investor Johnson & Johnson Innovation – JJDC, Inc. (JJDC) also participated in the funding, with existing investors Maveron and Northzone. Thirty Madison has raised a total of $70 million to date.
Thirty Madison, founded in 2017 by Steven Gutentag and Demetri Karagas, was launched with a single vision: To build the highest quality care experiences for treating chronic health conditions. Through Thirty Madison's three portfolio brands, Keeps, Cove, and Evens, patients can easily access specialist-level care combined with the convenience of telemedicine and treatment delivery. Each platform offers individualized health care to patients suffering from hair loss (Keeps), migraine (Cove), and acid reflux (Evens) at an affordable cost. With virtual doctor visits and a wide range of therapeutic treatments, tools, and educational content individually personalized to the needs of patients, these innovative brands are reimagining and enhancing the way chronic conditions are treated.
With this new investment, Thirty Madison plans to innovate in the digital healthcare space, specifically making the overall experience more enjoyable for those with chronic conditions. Steven Gutentag, co-founder and CEO of Thirty Madison, notes, "We are excited to have JJDC as an investor, given Johnson & Johnson's leadership across healthcare and consumer health, and their commitment to putting consumers and patients first."
Amy Schulman, managing partner at Polaris Partners, will also join Thirty Madison's Board of Directors. "Over 59 percent of Americans suffer from at least one chronic condition, but few resources exist to help them connect the dots of their care," said Schulman. "I have spent much of my career finding and implementing solutions predicated on putting patients first, and Thirty Madison represents the type of progress in healthcare that has become even more necessary and timely during this current moment."
Gutentag adds, "As the former president of Pfizer Consumer Healthcare, Amy has had a transformative influence on the consumer healthcare space, and we are thrilled to have her leadership and guidance on our board of directors. With this funding, we will further expand our availability to deliver expert care as well as launch new brands to treat more of the conditions Americans face."
Thirty Madison provides a differentiated platform that allows Keeps, Cove, and Evens to deliver specialist-level care across a range of health issues and a unique approach to modernizing healthcare. Apart from providing a variety of issue-appropriate treatment options, the brands partner directly with innovative healthcare companies to offer patients with increased access to the latest treatment options and offer meaningful cost savings.